Australia vaccine funding, Sinopharm’s global push, ECB accelerates stimulus
FT News Briefing
00:00
Intro
This chapter explores Australia's strategy to boost its COVID-19 vaccine production through biopharmaceutical investments while addressing challenges faced by China’s Sinopharm in expanding globally. It also highlights Spain's efforts to support gig workers amidst a complicated market landscape.
Play episode from 00:00
Transcript
